Bronchoscopic Interventional Therapy Combined With Pembrolizumab in the Treatment of Pulmonary Large Cell Neuroendocrine Carcinoma: A Case Report.

Fan, Yingyi; Wang, Yingying; Ji, Yanrong; Li, Shuang; Zhang, Jian; Hao, Xingliang

Fan, Yingyi; Wang, Yingying; Ji, Yanrong; Li, Shuang; Zhang, Jian; Hao, Xingliang.

Affiliation

Fan Y; Department of Respiratory and Critical Care Medicine, Shengli Oilfield Central Hospital, Dongying, China.
Wang Y; Clinical Pharmacy of Pharmacy Department, Shengli Oilfield Central Hospital, Dongying, China.
Ji Y; Department of Respiratory and Critical Care Medicine, Shengli Oilfield Central Hospital, Dongying, China.
Li S; Department of Respiratory and Critical Care Medicine, Shengli Oilfield Central Hospital, Dongying, China.
Zhang J; Department of Respiratory and Critical Care Medicine, Shengli Oilfield Central Hospital, Dongying, China.
Hao X; Department of Respiratory and Critical Care Medicine, Shengli Oilfield Central Hospital, Dongying, China.

Clin Respir J ; 18(9): e70009, 2024 Sep.

Article de En | MEDLINE | ID: mdl-39225701

ABSTRACT

ABSTRACT

This study reports a significant clinical outcome following the use of bronchoscopic interventional therapy combined with pembrolizumab for treating pulmonary large cell neuroendocrine carcinoma (LCNEC), showcasing a novel approach in managing this aggressive cancer.

Sujet(s)
Mots clés

central airway stenosis; large cell neuroendocrine carcinoma of the lung; pembrolizumab; photodynamic therapy

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Bronchoscopie / Carcinome neuroendocrine / Anticorps monoclonaux humanisés / Tumeurs du poumon Limites: Aged / Humans / Male / Middle aged Langue: En Journal: Clin Respir J Année: 2024 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google